BOTOX® in the Treatment of Crow's Feet Lines in China
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) compared
with placebo in patients with moderate to severe crow's feet lines (lateral canthal lines).
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA